🛰️ Daily AI Frontier
‹ back to 2026-08-24

Nature | 焦亡通路上的“借道入胞”——GSDMD孔介导的caspase抑制剂靶向递送

Research Medical/Healthcare AI

Ranking

Overall 70
Content 75
Popularity 58

Observed public metrics from 1 member.

Representative image for Nature | 焦亡通路上的“借道入胞”——GSDMD孔介导的caspase抑制剂靶向递送

Merged summary

TL;DR - A Nature study developed poorly membrane-permeable caspase inhibitors that enter pyroptotic cells through transient GSDMD pores, selectively suppressing inflammatory cell death while sparing apoptosis. The approach could enable safer anti-inflammatory therapies, although liver-enzyme elevations indicate further optimization is needed.

  • Screening identified selective covalent inhibitors of inflammatory caspases, including KGR-3 for human caspase-1/4 and KGR-53P for mouse caspase-1/11.
  • The inhibitors required GSDMD pores to enter cells, blocking pyroptosis and IL-1β/IL-18 release without disrupting apoptotic pathways.
  • Delayed treatment remained effective, showing a therapeutic window after initial GSDMD pore formation.
  • KGR-53P reduced inflammatory cytokines in a mouse endotoxin-shock model but raised liver enzymes without LPS, suggesting off-target toxicity.

Sources (1)

Nature | 焦亡通路上的“借道入胞”——GSDMD孔介导的caspase抑制剂靶向递送

WeChat: BioArt 2026-08-24 doi:10.1038/s41586-026-10957-y
Public signals OpenAlex citations 1
Providers: Hugging Face · N/A OpenAlex · Citations 1 Publisher · N/A Semantic Scholar · N/A X · N/A Fetched 2026-09-22 14:32:40.031323 UTC

TL;DR - A Nature study developed poorly membrane-permeable caspase inhibitors that enter pyroptotic cells through transient GSDMD pores, selectively suppressing inflammatory cell death while sparing apoptosis. The approach could enable safer anti-inflammatory therapies, although liver-enzyme elevations indicate further optimization is needed.

  • Screening identified selective covalent inhibitors of inflammatory caspases, including KGR-3 for human caspase-1/4 and KGR-53P for mouse caspase-1/11.
  • The inhibitors required GSDMD pores to enter cells, blocking pyroptosis and IL-1β/IL-18 release without disrupting apoptotic pathways.
  • Delayed treatment remained effective, showing a therapeutic window after initial GSDMD pore formation.
  • KGR-53P reduced inflammatory cytokines in a mouse endotoxin-shock model but raised liver enzymes without LPS, suggesting off-target toxicity.
item →